Search

everythinglearnresearchcommunity

for

Search:↓

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Four natural compounds were found to promote hair growth effectively.

Isoalantolactone promotes hair growth by activating specific cell pathways.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Overexpressing IGF-1 in mice leads to skin abnormalities and tumors.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

ASC-CM is more effective than EV for treating osteoarthritis.

Alkaline ceramidase 1 is crucial for healthy skin and energy balance.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

HMBi supplementation boosts cashmere growth by affecting specific metabolic and signaling pathways in goats.

Using drugs to activate the Wnt/β-catenin pathway has potential for treating diseases but also presents challenges.

Certain proteins are significantly increased in the skin of people with hidradenitis suppurativa.

Metformin promotes hair growth by affecting cell growth and protein signaling related to hair growth.

PPAR activation can improve diabetic wound healing by enhancing blood vessel function.

ING5 is crucial for stem cell maintenance and preventing certain cancers.

Isotretinoin at a low dose for three months does not significantly affect hair growth.

Intravenous and oral calcium effectively treated vitamin D dependent rickets type II, improving growth and bone health.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

A stable, active version of a growth factor was made in bacteria, showing promise for medical use.

Oral etretinate improved hair length and reduced beading in monilethrix.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Acitretin effectively improved the woman's skin condition.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.